RG

Rajesh Gautam

Active Director Director DIN 10079811
DIN 10079811 First appointment Mar 2023 Primary industry Paper
Unlock full profile Investments · shareholding · contact details
Current companies 1 active board seats
Total affiliations 1 Since Mar 2023
Shareholding value •••• Premium profile

About Rajesh Gautam

Data last updated:

Rajesh Gautam is a Director at Medispur Biotech Private Limited (since 2023). The company operates in Paper. Medispur Biotech Private Limited reported revenue of ₹1.43 Cr (FY 2025).

DIN 10079811
Primary Designation Director
Industry Paper
First Appointment 19 Mar 2023
Oldest Company Age 3 yrs
Largest company Medispur Biotech Private Limited · ₹1.43 Cr (FY 2025)

Current companies

CompanyDesignationAppointmentFoundedRevenueStatus
Medispur Biotech Private Limited U21001HP2023PTC009945
Director19 Mar 20232023₹1.43 Cr (FY 2025)Active

Board colleagues of Rajesh Gautam

NameDINCompanyDesignation
Jyoti Sharma10079812Medispur Biotech Private LimitedDirector

Directorship timeline

Open interactive timeline →
Medispur Biotech Private Limited
Premium access

Shareholding and investment profile for Rajesh Gautam

Company-level share counts, filed values, and quarterly changes require authenticated premium access.

  • Company-level holdings
  • Filed share counts
  • Reported values
  • Quarterly changes
Unlock shareholding

Verified entity values are shown only after access is granted.

Frequently Asked Questions about Rajesh Gautam

Rajesh Gautam currently holds 1 directorship: Medispur Biotech Private Limited (Director, since 19 Mar 2023, revenue ₹1.43 Cr (FY 2025)).

Rajesh Gautam was first appointed on 19 Mar 2023 as Director at Medispur Biotech Private Limited.

The current boards of Rajesh Gautam's companies include Jyoti Sharma (Medispur Biotech Private Limited).

Explore millions of companies — effortlessly

Access structured, verified intelligence on 7M+ companies across industries, sectors, and global markets. From early-stage startups to large enterprises, discover ownership, leadership, funding, financials, acquisitions, and market signals — all in one powerful platform.

Free account with essential features Instant access to company reports Enterprise solutions available